BioCryst's market cap is currently $1.60B. The company's EPS TTM is $0.02; its P/E ratio is ―; BioCryst is scheduled to report earnings on August 4, 2025, and the estimated EPS forecast is $0.04. See an overview of income statement, balance sheet, and cash flow financials.
